Who invested in Karus Therapeutics?
Karus Therapeutics's investors include SV Life Sciences, New Leaf Venture Partners, Novo Holdings A/S and International Biotechnology Trust Plc.
United Kingdom · Series B startup
Funding summaryUpdated 26 Oct 2026
$7.6Mraised across 1 round since 2012, from 1 source
Karus Therapeutics's investors include SV Life Sciences, New Leaf Venture Partners, Novo Holdings A/S and International Biotechnology Trust Plc.
Karus Therapeutics has raised $7.6M across 1 round since 2012.
Karus Therapeutics's most recent round was a Series B of $7.6M in Sept 2012.
Its most recent round, $7.6M in Sept 2012, is also its largest on record.
Karus Therapeutics's first round on record, in Sept 2012, was backed by SV Life Sciences, New Leaf Venture Partners and Novo Holdings A/S and 1 others.
Karus Therapeutics's latest named round is a Series B, in Sept 2012.
Karus Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.